Determination of Anticholinergic Medication Use in Patients Prescribed Medications for the Treatment of Dementia.

CONSULTANT PHARMACIST Pub Date : 2017-12-01 DOI:10.4140/TCP.n.2017.764

Brooke Ellard, John A Galdo

{"title":"Determination of Anticholinergic Medication Use in Patients Prescribed Medications for the Treatment of Dementia.","authors":"Brooke Ellard, John A Galdo","doi":"10.4140/TCP.n.2017.764","DOIUrl":null,"url":null,"abstract":"Objective: The primary endpoint of the study is to determine the variations in the use of medications to treat dementia in patients concomitantly or not prescribed anticholinergics.Design: The study is a case series of patients at a single community pharmacy over one year based on prescription claims data.Setting: The setting is an independent community pharmacy in the South.Main outcome measure(s): The main outcome is the variations associated in treatment plans for patients either receiving anticholinergics or not receiving medications with anticholinergic properties.Results: The community pharmacy had 33 patients on medications to treat dementia, and 17 patients (51.5%) were prescribed anticholinergic medications. Only patients on anticholinergic medications were prescribed memantine immediate-release. Fifteen patients (93%) not prescribed anticholinergic medications were on a single medication to treat dementia, whereas 9 patients (52%) prescribed anticholinergic medications were on a single medication to treat dementia.Conclusion: Further research should be conducted in this area to better ascertain the impact anticholinergic medications have on patients. This study noted differences from previous data regarding the prevalence of concomitant prescribing of medications for the treatment of dementia and anticholinergics.","PeriodicalId":45985,"journal":{"name":"CONSULTANT PHARMACIST","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4140/TCP.n.2017.764","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CONSULTANT PHARMACIST","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4140/TCP.n.2017.764","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 1

Abstract

Objective: The primary endpoint of the study is to determine the variations in the use of medications to treat dementia in patients concomitantly or not prescribed anticholinergics.

Design: The study is a case series of patients at a single community pharmacy over one year based on prescription claims data.

Setting: The setting is an independent community pharmacy in the South.

Main outcome measure(s): The main outcome is the variations associated in treatment plans for patients either receiving anticholinergics or not receiving medications with anticholinergic properties.

Results: The community pharmacy had 33 patients on medications to treat dementia, and 17 patients (51.5%) were prescribed anticholinergic medications. Only patients on anticholinergic medications were prescribed memantine immediate-release. Fifteen patients (93%) not prescribed anticholinergic medications were on a single medication to treat dementia, whereas 9 patients (52%) prescribed anticholinergic medications were on a single medication to treat dementia.

Conclusion: Further research should be conducted in this area to better ascertain the impact anticholinergic medications have on patients. This study noted differences from previous data regarding the prevalence of concomitant prescribing of medications for the treatment of dementia and anticholinergics.

查看原文本刊更多论文

测定痴呆患者处方药物中抗胆碱能药物的使用。

目的:本研究的主要目的是确定痴呆患者联合或不联合使用抗胆碱能药物治疗的差异。设计:该研究是基于处方索赔数据，对一个社区药房一年多的患者进行病例系列研究。设置:设置在南方一个独立的社区药房。主要结局指标:主要结局指标是接受抗胆碱能药物治疗或未接受抗胆碱能药物治疗的患者治疗方案的变化。结果:社区药房接受痴呆治疗的患者33例，接受抗胆碱能药物治疗的患者17例(51.5%)。只有服用抗胆碱能药物的患者才开美金刚立即释放。15名患者(93%)没有服用抗胆碱能药物治疗痴呆，而9名患者(52%)服用抗胆碱能药物治疗痴呆。结论:为更好地了解抗胆碱能药物对患者的影响，应进一步开展相关研究。这项研究注意到与先前关于痴呆和抗胆碱能药物治疗同时开处方的患病率的数据不同。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

CONSULTANT PHARMACIST PHARMACOLOGY & PHARMACY-

自引率

0.00%

发文量

期刊介绍： Vision ... The Society"s long-term desire, aspiration, and core purpose. The vision of the American Society of Consultant Pharmacists is optimal medication management and improved health outcomes for all older persons. Mission ... The Society"s strategic position, focus, and reason for being. The American Society of Consultant Pharmacists empowers pharmacists to enhance quality of care for all older persons through the appropriate use of medication and the promotion of healthy aging.